Successful treatment of chronic tophaceous gout with infliximab (Remicade).
Fiehn
Christoph
C
Department of Internal Medicine V, University of Heidelberg and Centre for Rheumatic Diseases, Rotenbachtalstr. 5, 76530 Baden-Baden, Germany. c.fiehn@rheumazentrum-baden.de
Zeier
Martin
M
D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006073:Gout / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab